Revive Therapeutics Ltd. (CSE:RVV)
0.0100
0.00 (0.00%)
Nov 20, 2026, 3:43 PM EST
Revive Therapeutics Company Description
Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders.
The company develops Bucillamine-based therapies, psilocybin-based therapeutics, and Long COVID diagnostics, as well as commercializes delivery technologies for psychedelics and cannabinoids.
Revive Therapeutics Ltd. was founded in 2012 and is based in Toronto, Canada.
Revive Therapeutics Ltd.

| Country | Canada |
| Founded | 2012 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2 |
| CEO | Michael Frank |
Contact Details
Address: The Canadian Venture Building Toronto, ON M5C 1P1 Canada | |
| Phone | 888-901-0036 |
| Website | revivethera.com |
Stock Details
| Ticker Symbol | RVV |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | CAD |
| ISIN Number | CA7615161030 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Michael Frank | Chairman and Chief Executive Officer |
| Carmelo Marrelli ACIS, B.Comm., C.A., C.P.A., CGA | Chief Financial Officer |
| Dr. Kelly T. McKee Jr., M.D., M.P.H. | Chief Scientific Officer Consultant |
| Dr. Onesmo Mpanju Ph.D. | Chief Regulatory Affairs Consultant |